172 related articles for article (PubMed ID: 32079256)
1. Combined Effect of HPV and Several Gene SNPs in Laryngeal Cancer.
Stumbrytė-Kaminskienė A; Gudlevičienė Ž; Dabkevičienė D; Mackevičienė I
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32079256
[No Abstract] [Full Text] [Related]
2. Individual and combined effect of
Stumbryte A; Gudleviciene Z; Kundrotas G; Dabkeviciene D; Kunickaite A; Cicenas S
Oncotarget; 2018 Jan; 9(3):3214-3229. PubMed ID: 29423041
[TBL] [Abstract][Full Text] [Related]
3. Significance of MDM2-309 polymorphisms and induced corresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma.
Zhou J; Liu F; Zhang D; Chen B; Li Q; Zhou L; Lu LM; Tao L
DNA Cell Biol; 2014 Feb; 33(2):88-94. PubMed ID: 24325471
[TBL] [Abstract][Full Text] [Related]
4. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
5. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E
Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
[TBL] [Abstract][Full Text] [Related]
7. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
8. The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Jakstas T; Bartnykaite A; Padervinskis E; Vegiene A; Juozaityte E; Uloza V; Ugenskiene R
BMC Cancer; 2024 Feb; 24(1):214. PubMed ID: 38360622
[TBL] [Abstract][Full Text] [Related]
9. Associations of Polymorphisms Localized in the 3'UTR Regions of the
Insodaite R; Smalinskiene A; Liutkevicius V; Ulozas V; Poceviciute R; Bielevicius A; Kucinskas L
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828284
[TBL] [Abstract][Full Text] [Related]
10. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.
Hassumi-Fukasawa MK; Miranda-Camargo FA; Guimarães MC; Simões RT; Donadi EA; Soares CP; Soares EG
Eur Arch Otorhinolaryngol; 2012 Jul; 269(7):1795-804. PubMed ID: 22310835
[TBL] [Abstract][Full Text] [Related]
11. Association study of cell cycle proteins and human papillomavirus in laryngeal cancer in Chinese population.
Cui L; Qu C; Liu H
Clin Otolaryngol; 2019 May; 44(3):323-329. PubMed ID: 30681775
[TBL] [Abstract][Full Text] [Related]
12. The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome.
Zhang D; Tang WJ; Tang D; Zhou J; Chou L; Tao L; Lu LM
Acta Otolaryngol; 2016 Aug; 136(8):826-33. PubMed ID: 27080151
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer.
Escalante P; Barría T; Cancino M; Rahal M; Cerpa L; Sandoval C; Molina-Mellico S; Suárez M; Martínez M; Cáceres DD; Quiñones LA; Varela NM
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338278
[TBL] [Abstract][Full Text] [Related]
14. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort.
Stephen JK; Chen KM; Shah V; Havard S; Lu M; Schweitzer VP; Gardner G; Worsham MJ
Otolaryngol Head Neck Surg; 2012 May; 146(5):730-8. PubMed ID: 22267491
[TBL] [Abstract][Full Text] [Related]
16. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang.
Sun J; Xiong J; Zhen Y; Chen ZL; Zhang H
Asian Pac J Cancer Prev; 2012; 13(11):5439-44. PubMed ID: 23317197
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
18. The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.
Wittekindt C; Wuerdemann N; Gattenlöhner S; Brobeil A; Wierzbicka M; Wagner S; Klußmann JP
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3837-3842. PubMed ID: 28861601
[TBL] [Abstract][Full Text] [Related]
19. Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.
Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
Cancer Biomark; 2022; 34(2):175-188. PubMed ID: 34719479
[TBL] [Abstract][Full Text] [Related]
20. [Study on HPV infection and p53 protein expression in laryngeal carcinoma].
Qin Z; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Dec; 11(12):546-9. PubMed ID: 10323025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
